FUJIFILM Announces Start in USA of Clinical Phase II Trial of Antiviral Drug AVIGAN for COVID-19 Patients

Fujifilm has just issued a press release, where they officially announce that their anti-influenza virus drugs “Avigan ® Tablets” has started a clinical phase II study in patients new coronavirus infection in the United States.

The purpose of this study is to confirm the therapeutic efficacy and safety of Avigan.

The study is scheduled to be conducted at three facilities: Brigham and Women’s Hospital, Massachusetts General Hospital, and Massachusetts State University Medical School.

In case you are unaware of the different phases, down below is a table taken from wikipedia.

In Japan, they are at Phase III of the tests already, as we reported here.

Press Release

** CLICK HERE to Read the Rest of the Article **

Fujifilm Manager: “New Fujifilm X-T3 Firmware Update? Fuji’s Philosophy is Not to Abandon Products Once a Successor it Out”

Foto EmaTV had an 1+ hour long skype interview with Italian Fujifilm manager Riccardo Scotti. They talk about the Fujifilm X-T4.

Lucky you that I speak Italian, so down below is a summary.

Most important: he can’t say anything, but the way he formulated it, he made hopes for a major Fujifilm X-T3 firmware update. Read it down below.

Also, a little titbit nobody reported about. Do you know that little synch terminal cap that you (and me) keep losing? Well, looks like Fujifilm has improved the mechanism and it should stick better on the camera.

If you are interested, read more down below.

Summary

** CLICK HERE to Read the Rest of the Article **

Fujifilm Drug Avigan (Favipiravir) For COVID-19 (Coronavirus) Treatment Tested Worldwide (USA included) and Offered for Free to 20 Countries

Last month we reported how Zhang Xinmin, director of the science ministry’s China National Center for Biotechnology Development, said that the Fujifilm produced drug Avigan “has a high degree of safety and is clearly effective in treatment” and how a Japanese health ministry source suggested the drug was not as effective in people with more severe symptom.

A few days later, Fujifilm published another official statement, where they announce the start of phase III clinical trial of “Avigan” on COVID-19 Coronavirus and the commitment to increase production.

Avigan is currently tested all over the world, including here in Italy, where I live. But also in USA and many other countries.

Moreover, Japan plans to provide the anti-flu drug Avigan for free to 20 countries hoping to use it to treat coronavirus patients, Foreign Minister Toshimitsu Motegi said Tuesday.

As a consequence, Fujifilm ramped up production of flu drug Avigan as possible COVID-19 treatment.

Fujifilm or not, let’s hope some cure comes up soon, or this unreal situation will keep up for a long time.

Our Owners Groups

Our Facebook Pages

via japantimes via fiercepharma via nypost

CamFi Adds Wireless Tethering Support for Fujifilm Cameras

A few days ago, CamFi has just released a new version of their wireless tethering app that adds support for the following Fujifilm cameras.

  • Fujifilm X-T2
  • Fujifilm X-T3
  • Fujifilm X-H1
  • Fujifilm GFX 50R
  • Fujifilm GFX 50S
  • Fujifilm GFX 100

CamFi products can be found at BHphoto and AmazonUS.

You can download the CamFi App at the Apple Store here and at Google Play Store.

What’s New
Apr 3, 2020

Version 3.7.1

  • Support Fujinon Camera X-T2, X-T3, X-H1, GFX 50S, GFX 50R, GFX 100
  • Support Sony a6100, a6600
  • Support Canon 90D